Fig. 1.
Fig. 1. Expression of TCR-Vβ22 on fresh circulating tumor cells. / We performed 3-color flow cytometric analysis using FITC-conjugated anti–TCR-Vβ22, anti–CD8α-ECD, and anti–CD4-PE mAbs.

Expression of TCR-Vβ22 on fresh circulating tumor cells.

We performed 3-color flow cytometric analysis using FITC-conjugated anti–TCR-Vβ22, anti–CD8α-ECD, and anti–CD4-PE mAbs.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal